Contact CADC Program

CADC Leadership

  • Dan Mungas, PhD
    Director / Principal Investigator

    Dan Mungas, PhD is a Professor of Neurology at UC Davis. He has been at UC Davis since 1981 and has been associated with the UC Davis CADC program since it began in 1986. Dr. Mungas has longstanding experience and expertise in clinical care related to cognitive changes of aging, and diseases that cause cognitive decline. His clinical background in Alzheimer's disease and related dementias is complemented by a research program that both derives from clinical experience and contributes findings to guide clinical care. Dr. Mungas is particularly interested in measuring cognitive change in demographically and linguistically diverse older persons and understanding the factors that influence cognitive decline. Much of his research involves ethnically diverse participant samples, with particular emphasis on Hispanics, African Americans, and Caucasians.

  • Bruce Reed, PhD
    Director / Principal Investigator

    Bruce R. Reed, PhD, a professor of neurology at University of California Davis and staff psychologist for the Department of Veterans Affairs Northern California Health Care System, is the principal investigator for the UCD-Martinez California Alzheimer's Disease Center. He is a recognized expert in the assessment and management of dementing illness and has published over 100 articles in the field. His interests include understanding how vascular disease contributes to dementia, the measurement of cognitive function in old age, especially in minority elders, and how cognitive reserve and other lifetime factors make us more or less susceptible to dementia.

  • Bruce L. Miller, MD
    Director / Principal Investigator

    Bruce L. Miller, MD, is Professor of Neurology at the University of California, San Francisco (UCSF) where he holds the A.W. & Mary Margaret Clausen Distinguished Chair. Dr. Miller directs the busy UCSF dementia center where patients in the San Francisco Bay Area receive comprehensive clinical evaluations. His goal is the delivery of model care to all of the patients who enter the clinical and research programs at the UCSF Memory and Aging Center. Dr. Miller teaches extensively and runs the Behavioral Neurology Fellowship at UCSF.

  • Jared Tinklenberg, MD
    Director / Principal Investigator

    Jared Tinklenberg, MD, Professor of Psychiatry and Behavioral Science at Stanford School of Medicine, is the Principal Investigator for the Stanford/VA-Palo Alto California Alzheimer's Disease Center. Dr. Tinklenberg is also the program director of Stanford's School of Medicine Geriatric Psychiatric Training Program. His research interests include: psychopharmacology of dementia and Alzheimer's disease; biological correlates of Alzheimer's disease; sexual dysfunction in, Alzheimer's disease; and memory disorders.

  • Loren Alving, MD
    Director / Principal Investigator

    Loren Alving, MD, is the Principal Investigator for the California Alzheimer’s Disease Center at UCSF Fresno and is a Co-Director of UCSF Fresno Alzheimer’s & Memory Center. Dr. Alving is board certified in neurology and has subspecialty certification in behavioral neurology. Dr. Alving’s research interests include dementia, Alzheimer’s Disease, Frontotemporal Dementia and Dementia with Lewy bodies. Dr. Alving is involved in several clinical studies relating to these areas.

  • Carl W. Cotman, PhD
    Director / Principal Investigator

    Carl W. Cotman, PhD, the Founding Director of the UC Irvine Institute for Memory Impairments and Neurological Disorders (formerly the Institute for Brain Aging and Dementia), is the principal investigator for the UC Irvine California Alzheimer's Disease Center. Dr. Cotman's research is focused on understanding the mechanisms causing neuronal degeneration in Alzheimer's disease (AD) and the development of interventions to promote successful aging, and to evaluate intervention strategies in elderly humans in collaboration with other investigators in the field. In 2008 Dr. Cotman received a lifetime achievement award for his research on Alzheimer's disease at the 11th International Conference on Alzheimer's Disease in Chicago. The award is given to outstanding scientists who have dedicated themselves to helping millions of people around the world through their research.

  • Interim Director

    David B. Teplow, Ph.D., Professor of Neurology, David Geffen School of Medicine at UCLA, and Director, UCLA Biopolymer Laboratory, is the Interim Director of the UCLA California Alzheimer's Disease Center. Dr. Teplow has had a life-long fascination with mechanisms of human diseases, first doing seminal work on the scrapie prion problem, in collaboration with Drs. Leroy Hood (Caltech) and Stanley Prusiner (UCSF), and for the last two decades working on the Alzheimer's disease problem. Dr. Teplow recently was recognized as one of the world's top 100 Alzheimer's disease researchers.

  • Lon Schneider, MD
    Director / Principal Investigator

    Lon Schneider, MD, MS is Professor of Psychiatry, Neurology, and Gerontology at the Keck School of Medicine of the University of Southern California. He is director of the California Alzheimer's Disease Center, the Department of Psychiatry Geriatric Studies Center and co-director of the clinical core of the University of Southern California Alzheimer's Disease Research Center (National Institutes of Health). In addition, he is principal investigator of the National Institute of Mental Health's CATIE program, a multicenter effectiveness trial of atypical antipsychotics in Alzheimer's disease.

  • Freddi Segal-Gidan, PA, PhD
    Director / Principal Investigator

    Freddi Segal-Gidan, PA, PhD is a physician assistant and gerontologist. Dr. Segal-Gidan is the director of the Rancho/USC California Alzheimer's Disease Center, and holds appointments as assistant clinical professor, department of neurology and family medicine in the Keck School of Medicine, University of Southern California (USC), and assistant clinical professor of gerontology at the L. Davis School of Gerontology at USC. Dr. Segal-Gidan received her medical training at the Johns Hopkins University Health Associate Program and was awarded her doctoral degree in gerontology-public policy from the University of Southern California Leonard Davis School of Gerontology.

  • Douglas R. Galasko, MD
    Director / Principal Investigator

    Douglas R. Galasko, MD is a Professor In Residence, Department of Neurosciences. Dr. Galasko has made important original research contributions in the area of Alzheimer’s disease (AD) and dementia with Lewy bodies (DLB). Specific areas of investigation include biological markers and genetic risk factors for AD, heterogeneity in AD, and subtypes and variants such as DLB. He has also been active in improving clinical measurement in AD, especially indices of progression. His fields of interest includes clinical research pertaining to Alzheimer’s disease and neurological problems associated with aging. Dr. Galasko provides formal courses and lectures as well as individual instruction to medical students, residents, and fellows in a variety of settings, including the inpatient service and several outpatient clinics at the UCSD and VA San Diego Medical Centers.

  • Pat Fox, PhD
    Principal Investigator

    Patrick Fox, PhD, co-Director at the Institute for Health & Aging and Professor of Sociology and Health Policy in the Department of Social and Behavioral Sciences, is the principal investigator for the evaluation component of the California Alzheimer's Disease Centers. Dr. Fox's interests include the sociology of aging, long-term care, evaluation of social and health interventions, health policy, disease-based social movements, economic costs of illness, and health promotion. He has written numerous reports and articles on the delivery of community-based long-term care and mental health services to the elderly, evaluation of community-based health promotion interventions for the elderly, Alzheimer's disease, the economic costs of disease, and clinical quality improvement.